We retrospectively reviewed records of treatment-naïve adult patients with ESRD and chronic HCV infection who had been treated with Peg-IFN and low-dose ribavirin using a RGT approach.
Treatments with interferon (IFN-α2a) and pegylated IFN are currently the only treatments that achieve a cure rate of about 30-45% of ESRD patients with chronic HCV infection.